Moxifloxacin

This is not medical advice. Always consult a licensed healthcare professional before starting or changing any treatment. Information here is based on personal experiences and may not apply to everyone.

Alternative Names: Avelox

Moxifloxacin is a fluoroquinolone antibiotic commonly used to treat community-acquired pneumonia (CAP) caused by susceptible bacteria. It is particularly useful for atypical pneumonia caused by organisms such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila.

As a fluoroquinolone, it has potential side effects of QT prolongation (risk of arrhythmias), tendinitis/tendon rupture (higher risk in elderly), peripheral neuropathy, and Clostridium difficile infection (diarrhea)

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the limited information provided, which includes only one review with a rating of 4 out of 5, Moxifloxacin appears to be an effective treatment for outpatient community-acquired pneumonia. However, with just a single review and no detailed content, it is difficult to draw a definitive conclusion about the overall effectiveness of this treatment.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost

5.0

1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable

Relief Speed

3.0

1 = No Relief 5 = Immediate Relief

3.0

Moderate Relief

Side Effects

3.0

1 = Intolerable Effect 5 = No Effect

3.0

Moderate Effect

Treatment Line

3.0

1 = Third-line or more 5 = First-line

3.0

Second Line

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews

100%

AI Summary of User Experiences

Not medical advice.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost

Very Expensive

$1000+

Expensive

$501 to $1000

Moderate Cost

$101 to $500

Affordable

$25 to $100

Very Affordable

$25

Relief Speed

No Relief

No noticeable improvement

Slow Relief

Several days to weeks

Moderate Relief

Within 1 - 3 days

Fast Relief

Within hours

Immediate Relief

Within minutes

Side Effect

Intolerable Side Effect

Caused treatment to stop or required hospitalization

Severe Side Effect

Difficult to tolerate, may require intervention

Moderate Side Effect

Noticeable, but manageable

Mild Side Effect

Minor, not bothersome

No Side Effect

Without any adverse effects

Treatment Line

Third-line or more

Used after second-line failed or multiple prior treatment

Second-line

Used after first-line treatment failed or was unsuitable

First-line

First treatment tried

Dr. Curbside

Verified

Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add

2 months ago

An option for outpatient pneumonia when there’s a higher level of concern or need for broader coverage, including atypicals. Convenient as monotherapy, but should be used selectively. Important to weigh risks, especially QT prolongation and tendon rupture, before choosing it.

#VeryAffordable #CoveredByInsurance #ModerateRelief #ModerateEffect #Second-line #Rescue/EmergencyUse

View Professional Disclosures

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All